These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 33687528)

  • 1. Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis.
    Wang Q; Liu J; Shao R; Han X; Su C; Lu W
    Rheumatol Int; 2021 May; 41(5):851-861. PubMed ID: 33687528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data.
    Xu C; Yi Z; Cai R; Chen R; Thong BY; Mu R
    Autoimmun Rev; 2021 Apr; 20(4):102778. PubMed ID: 33609804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review.
    Bakasis AD; Mavragani CP; Boki KA; Tzioufas AG; Vlachoyiannopoulos PG; Stergiou IE; Skopouli FN; Moutsopoulos HM
    J Autoimmun; 2021 Sep; 123():102687. PubMed ID: 34311142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis.
    Wang F; Ma Y; Xu S; Liu H; Chen Y; Yang H; Shao M; Xu W; Kong J; Chen L; Xu S; Shuai Z; Pan F
    Clin Rheumatol; 2022 Jul; 41(7):2213-2223. PubMed ID: 35352217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death: A Systematic Review and Meta-analysis.
    Ceban F; Nogo D; Carvalho IP; Lee Y; Nasri F; Xiong J; Lui LMW; Subramaniapillai M; Gill H; Liu RN; Joseph P; Teopiz KM; Cao B; Mansur RB; Lin K; Rosenblat JD; Ho RC; McIntyre RS
    JAMA Psychiatry; 2021 Oct; 78(10):1079-1091. PubMed ID: 34319365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark.
    Cordtz R; Lindhardsen J; Soussi BG; Vela J; Uhrenholt L; Westermann R; Kristensen S; Nielsen H; Torp-Pedersen C; Dreyer L
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI59-SI67. PubMed ID: 33369663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-Analysis.
    Conway R; Grimshaw AA; Konig MF; Putman M; Duarte-García A; Tseng LY; Cabrera DM; Chock YPE; Degirmenci HB; Duff E; Egeli BH; Graef ER; Gupta A; Harkins P; Hoyer BF; Jayatilleke A; Jin S; Kasia C; Khilnani A; Kilian A; Kim AHJ; Lin CMA; Low C; Proulx L; Sattui SE; Singh N; Sparks JA; Tam H; Ugarte-Gil MF; Ung N; Wang K; Wise LM; Yang Z; Young KJ; Liew JW; Grainger R; Wallace ZS; Hsieh E;
    Arthritis Rheumatol; 2022 May; 74(5):766-775. PubMed ID: 34807517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry.
    Isnardi CA; Roberts K; Saurit V; Petkovic I; Báez RM; Quintana R; Tissera Y; Ornella S; D Angelo Exeni ME; Pisoni CN; Castro Coello VV; Berbotto G; Haye Salinas MJ; Velozo E; Reyes Torres ÁA; Tanten R; Zelaya MD; Gobbi C; Alonso CG; de Los Ángeles Severina M; Vivero F; Paula A; Cogo AK; Alle G; Pera M; Nieto RE; Cosatti M; Asnal C; Pereira D; Albiero JA; Savio VG; Maldonado FN; Gamba MJ; Germán NF; Baños A; Gallino Yanzi J; Gálvez Elkin MS; Morbiducci JS; Martire MV; Maldonado Ficco H; Schmid MM; Villafañe Torres JA; de Los Ángeles Correa M; Medina MA; Cusa MA; Scafati J; Agüero SE; Lloves Schenone NM; Soriano ER; Graf C; Pons-Estel BA; Gomez G; Landi M; De la Vega MC; Pons-Estel GJ;
    Clin Rheumatol; 2023 Feb; 42(2):563-578. PubMed ID: 36201124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry.
    Gianfrancesco MA; Leykina LA; Izadi Z; Taylor T; Sparks JA; Harrison C; Trupin L; Rush S; Schmajuk G; Katz P; Jacobsohn L; Hsu TY; D'Silva KM; Serling-Boyd N; Wallwork R; Todd DJ; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Machado PM; Robinson PC; Yazdany J;
    Arthritis Rheumatol; 2021 Mar; 73(3):374-380. PubMed ID: 33146001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases.
    Clemente D; Udaondo C; de Inocencio J; Nieto JC; Del Río PG; Fernández AG; Palomo JA; Bachiller-Corral J; Lopez Robledillo JC; Millán Longo C; Leon L; Abasolo L; Boteanu A
    Pediatr Rheumatol Online J; 2021 Nov; 19(1):162. PubMed ID: 34838054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of COVID-19 re-infections: a single-center cohort of 167 patients with systemic rheumatic diseases.
    Panagiotopoulos A; Fragoulis GE; Arida A; Bournia VK; Evangelatos G; Fragkiadaki K; Kravvariti E; Laskari K; Mylona M; Michalakeas N; Papazoglou N; Pappa M; Poulia V; Panopoulos S; Ziarangali S; Papatheodorou V; Tektonidou MG; Sfikakis PP
    Rheumatol Int; 2024 Sep; 44(9):1733-1737. PubMed ID: 38548908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients.
    FAI2R /SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors
    Ann Rheum Dis; 2021 Apr; 80(4):527-538. PubMed ID: 33268442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up.
    Gamboa-Cárdenas RV; Barzola-Cerrón S; Toledo-Neira D; Reátegui-Sokolova C; Pimentel-Quiroz V; Zevallos-Miranda F; Alarcón GS; Ugarte-Gil M
    Clin Rheumatol; 2021 Nov; 40(11):4725-4734. PubMed ID: 34189675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course and outcomes of COVID-19 in rheumatic disease patients: a case cohort study with a diverse population.
    Arleo T; Tong D; Shabto J; O'Keefe G; Khosroshahi A
    Clin Rheumatol; 2021 Jul; 40(7):2633-2642. PubMed ID: 33420870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-existing cerebrovascular disease and poor outcomes of COVID-19 hospitalized patients: a meta-analysis.
    Patel U; Malik P; Shah D; Patel A; Dhamoon M; Jani V
    J Neurol; 2021 Jan; 268(1):240-247. PubMed ID: 32770412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
    Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS
    JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do rheumatic diseases, long-term glucocorticoids, and immunosuppressant treatment, and vaccination impact the COVID-19 severity? Insight from a retrospective cohort study.
    Ma Y; Wei C; Yi Z; Song Z; Cheng Y; Zeng L; Zhao R; Mu R
    Int J Rheum Dis; 2024 Jul; 27(7):e15251. PubMed ID: 38982615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
    Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S
    Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 in Patients With Rheumatic Diseases: Is There a Need to Worry?
    Sachdeva S; Manaktala P; Malik FA; Gupta U; Desai R
    J Clin Rheumatol; 2022 Mar; 28(2):e401-e406. PubMed ID: 33902097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related risk factors and severity of SARS-CoV-2 infection: a systematic review and meta-analysis.
    Rahman MM; Bhattacharjee B; Farhana Z; Hamiduzzaman M; Chowdhury MAB; Hossain MS; Siddiqee MH; Islam MZ; Raheem E; Uddin MJ
    J Prev Med Hyg; 2021 Jun; 62(2):E329-E371. PubMed ID: 34604574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.